Showing results (911-920 of 996) with videos related to
Sort By:
Pageof 100
Molecular Psychiatry|December 17, 1997
An integrated physical map of 18p11.2: a susceptibility region for bipolar disorderL E Esterling, T Cox Matise, A R Sanders, et al.The Journal of Pharmacy and Pharmacology|March 15, 2000
Facile synthesis of a chitosan hybrid of a laminin-related peptide and its antimetastatic effect in miceK Hojo, M Maeda, Y Mu, et al.Molecular Psychiatry|October 14, 2000
Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCyclerT Toyota, A Watanabe, H Shibuya, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 15, 2010
Impaired gastric ulcer healing in diabetic mice: role of methylglyoxalY Naito, T Takagi, T Oya-Ito, et al.Journal of Clinical Gastroenterology|January 1, 1997
Monochloramine-induced cell growth inhibition and apoptosis in a rat gastric mucosal cell lineY Naito, T Yoshikawa, T Fujii, et al.European Heart Journal|April 1, 1996
Cardiac adrenergic receptor effects of carvedilolT Yoshikawa, J D Port, K Asano, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2008
The association of genetic variants in Krüppel-like factor 11 and Type 2 diabetes in the Japanese populationT Tanahashi, K Shinohara, P Keshavarz, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1994
Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans?T Nakamura, C H Turner, T Yoshikawa, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 22, 2003
Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetesA Kitamura, G Hasegawa, H Obayashi, et al.Alimentary Pharmacology & Therapeutics|August 20, 2003
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trialT Fujioka, T Arakawa, T Shimoyama, et al.Pageof 100